BR9901429A - Purine derivatives having cyclopropane ring - Google Patents
Purine derivatives having cyclopropane ringInfo
- Publication number
- BR9901429A BR9901429A BR9901429A BR9901429A BR9901429A BR 9901429 A BR9901429 A BR 9901429A BR 9901429 A BR9901429 A BR 9901429A BR 9901429 A BR9901429 A BR 9901429A BR 9901429 A BR9901429 A BR 9901429A
- Authority
- BR
- Brazil
- Prior art keywords
- group
- carbon atoms
- substituted
- cyclopropane ring
- hydrogen atom
- Prior art date
Links
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Patente de Invenção: <B>"DERIVADOS DE PURINA TENDO ANEL DE CICLOPROPANO"<D>. Um derivado de purina tendo um anel de ciclopropano representado pela fórmula (I): na qual A é um grupo -CH~ 2~- ou um grupo -CO-; X^ 1^ é um átomo de hidrogênio, um átomo de halogênio, um grupo alcóxi tendo 1 a 10 átomos de carbono, ou um grupo hidroxila; cada um de X^ 2^, X^ 3^ e X^ 4^ é independentemente, um átomo de hidrogênio ou um átomo de halogênio; R^ 1^ é um átomo de hidrogênio, um átomo de halogênio ou um grupo amino protegido ou desprotegido; e cada um de R^ 2^ e R^ 3^ é independentemente um átomo de hidrogênio, um grupo alquila substituído ou não-substituído tendo de 1 a 7 átomos de carbono, um grupo aralquila substituído ou não-substituído tendo de 7 a 11 átomos de carbono, ou um grupo acila substituído ou não-substituído tendo de 1 a 7 átomos de carbono, com a condição de que no caso em que A é um grupo -CO-, nem R^ 2^ nem R^ 3^ é um grupo acila substituído ou não substituído tendo de 1 a 7 átomos de carbono; e cada um de X^ 3^ e X^ 4^ é independentemente um átomo de halogênio, e um processo para preparação do mesmo.Invention Patent: <B> "PURINE DERIVATIVES HAVING CYCLOPROPANE RING" <D>. A purine derivative having a cyclopropane ring represented by formula (I): in which A is a -CH ~ 2 ~ - group or a -CO- group; X ^ 1 ^ is a hydrogen atom, a halogen atom, an alkoxy group having 1 to 10 carbon atoms, or a hydroxyl group; each of X ^ 2 ^, X ^ 3 ^ and X ^ 4 ^ is independently a hydrogen atom or a halogen atom; R ^ 1 ^ is a hydrogen atom, a halogen atom or a protected or unprotected amino group; and each of R ^ 2 ^ and R ^ 3 ^ is independently a hydrogen atom, a substituted or unsubstituted alkyl group having 1 to 7 carbon atoms, a substituted or unsubstituted aralkyl group having 7 to 11 carbon atoms, or a substituted or unsubstituted acyl group having from 1 to 7 carbon atoms, with the proviso that in the case where A is a -CO- group, neither R ^ 2 ^ nor R ^ 3 ^ is a substituted or unsubstituted acyl group having 1 to 7 carbon atoms; and each of X ^ 3 ^ and X ^ 4 ^ is independently a halogen atom, and a process for preparing it.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP10133349A JPH11322749A (en) | 1998-05-15 | 1998-05-15 | Production of opened cyclopropane ring compound |
JP10182765A JP2000016993A (en) | 1998-06-29 | 1998-06-29 | Purine derivative containing cyclopropane ring |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9901429A true BR9901429A (en) | 2001-03-20 |
Family
ID=26467727
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9901429A BR9901429A (en) | 1998-05-15 | 1999-05-11 | Purine derivatives having cyclopropane ring |
Country Status (2)
Country | Link |
---|---|
AR (1) | AR018343A1 (en) |
BR (1) | BR9901429A (en) |
-
1999
- 1999-05-07 AR ARP990102174 patent/AR018343A1/en unknown
- 1999-05-11 BR BR9901429A patent/BR9901429A/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
AR018343A1 (en) | 2001-11-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0109851A (en) | Compound, method for producing the same or a salt thereof, prodrug, pharmaceutical composition, method for inhibiting tyrosine kinase, method for preventing or treating cancer, and use of a compound or salt or prodrug thereof | |
BR0114253A (en) | Metabotropic Glutamate Receptor Antagonists | |
NO992549L (en) | Sugar compound, gelling agent and process for preparation thereof | |
BR0206670A (en) | Halogenated compounds exhibiting thrombopoietin receptor agonism | |
BR0212185A (en) | Compounds and methods for the preparation of compounds | |
BR0015809A (en) | Aqueous colloidal dispersion, process of preparing a dispersion, and use of a dispersion | |
CA2217771A1 (en) | O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same | |
BR9911491A (en) | Process of treatment of a metallic surface to increase the resistance against corrosion, and, use of a treatment solution | |
PT92378A (en) | PROCESS FOR THE PREPARATION OF CHROMAN DERIVATIVES, ACTIVES ON THE CENTRAL NERVOUS SYSTEM | |
EP0806413A4 (en) | 2-substituted vitamin d 3? derivatives | |
BR0111915A (en) | 5-aminoalkylpyrazolo [4,3-d] pyrimidines | |
BR0113584A (en) | Cromanone derivatives | |
PT89120A (en) | PROCESS FOR THE PREPARATION OF NEW SUBSTITUTED 2-PIPERAZINYL-2-OXO-ETHYLENE FLAVONOID DERIVATIVES | |
BR9901429A (en) | Purine derivatives having cyclopropane ring | |
BR9914438A (en) | Improved process for preparing new anti-diabetic agents | |
BR9910112A (en) | Methods for inhibiting mrp1 | |
DE60223227D1 (en) | BenzoÄbÄthiophenderivate and process for their preparation | |
ES2176914T3 (en) | DERIVED FROM THE PURINE THAT HAVE A CYCLOPROPAN RING. | |
ES2157292T3 (en) | 6-AZAINDOL INHIBITORS OF THE TROMBOXAN SINTASA. | |
BR9914780A (en) | Process of preparing a compound of formula (i) and compound produced by such a process | |
BR0212770A (en) | Mandelate salts of tetracyclically substituted tetrahydrofuran derivatives | |
BR9901201A (en) | Titanium Compound | |
BR9907458A (en) | Agent for dyeing fibers with 1,3-indandiones and aromatic amines | |
BR0004578A (en) | Acylation process | |
BR0009856A (en) | Synthesis of 3-amino-3-aryl propanoates |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25A | Requested transfer of rights approved |
Free format text: SUMITOMO CHEMICAL CO., LTD. (JP) |
|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AO NAO RECOLHIMENTO DA(S) 8A, 9A E 10A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1990 DE 25/02/2009. |